Akebia Secures 2043 Patents for Vafseo & $140M Loan, Strengthening HIF Therapy Outlook
Akebia Therapeutics extends Vafseo patents to 2043, secures up to $140 M in new financing, strengthening its HIF‑therapy lead and boosting investor confidence.
3 minutes to read

